Zai Lab (ZLAB) Other Non Operating Income (2020 - 2026)
Zai Lab (ZLAB) reported Other Non Operating Income of $14.8 million for Q1 2026, up 2179.11% on a YoY basis from $651000.0 in Q1 2025, and down 10.33% sequentially from $16.5 million in Q4 2025.
Zai Lab (ZLAB) Other Non Operating Income (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 7 years of Other Non Operating Income data on file, last reported at $14.8 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 2179.11% year-over-year to $14.8 million; the trailing twelve-month figure through Mar 2026 stood at $34.6 million (up 378.83% YoY), and the FY2025 full-year result was $19.6 million, up 229.42% from the prior year.
- Other Non Operating Income eased to $14.8 million in Q1 2026, from $16.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $16.5 million in Q4 2025 to a low of -$40.4 million in Q3 2022.
- A 5-year average of -$2.8 million and a median of $651000.0 in 2025 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 571.17% in 2022 and surged 3569.29% in 2024, its largest moves.
- Tracing ZLAB's Other Non Operating Income over 5 years: stood at $9.5 million in 2022, then sank by 258.2% to -$15.1 million in 2023, then sank by 55.36% to -$23.4 million in 2024, then surged by 170.66% to $16.5 million in 2025, then dropped by 10.33% to $14.8 million in 2026.
- Business Quant data shows ZLAB's Other Non Operating Income at $14.8 million in Q1 2026, $16.5 million in Q4 2025, and -$508000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.84 Mn |
| Dec 31, 2025 | 16.55 Mn |
| Sep 30, 2025 | -508,000.00 |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 651,000.00 |
| Dec 31, 2024 | -23.42 Mn |
| Sep 30, 2024 | 14.46 Mn |
| Jun 30, 2024 | -4.11 Mn |
| Mar 31, 2024 | 9.36 Mn |
| Dec 31, 2023 | -15.07 Mn |
| Sep 30, 2023 | 394,000.00 |
| Jun 30, 2023 | -1.41 Mn |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 9.53 Mn |
| Sep 30, 2022 | -40.44 Mn |
| Jun 30, 2022 | -34.90 Mn |
| Mar 31, 2022 | 2.29 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | -13.58 Mn |
| Jun 30, 2021 | 7.41 Mn |